CARDINAL HEALTH, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 108.2 USD | +2.07% |
|
+2.94% | +7.33% |
| Apr. 17 | AdaptHealth Names Suzanne Foster CEO | DJ |
| Apr. 02 | Cardinal Health Announces Location of Pharmaceutical Distribution Center for Over-The-Counter Products | CI |
Financials (USD)
| Sales 2024 * | 227B | Sales 2025 * | 246B | Capitalization | 25.78B |
|---|---|---|---|---|---|
| Net income 2024 * | 1.22B | Net income 2025 * | 1.6B | EV / Sales 2024 * | 0.11 x |
| Net cash position 2024 * | 326M | Net cash position 2025 * | 1.13B | EV / Sales 2025 * | 0.1 x |
| P/E ratio 2024 * |
17.8
x | P/E ratio 2025 * |
15.1
x | Employees | 47,520 |
| Yield 2024 * |
1.91% | Yield 2025 * |
1.95% | Free-Float | 74.12% |
More Fundamentals
* Assessed data
More news
Latest transcript on Cardinal Health, Inc.
More recommendations
More press releases
| 1 day | +2.07% | ||
| 1 week | +1.08% | ||
| Current month | -3.32% | ||
| 1 month | -3.31% | ||
| 3 months | +2.71% | ||
| 6 months | +17.11% | ||
| Current year | +7.33% |
1 week
105.53
108.42
1 month
104.92113.04
Current year
100.36116.04
1 year
77.56116.04
3 years
45.85116.04
5 years
39.05116.04
10 years
39.05116.04
| Managers | Title | Age | Since |
|---|---|---|---|
Jason Hollar
CEO | Chief Executive Officer | 51 | 20-04-26 |
Aaron Alt
DFI | Director of Finance/CFO | 53 | 23-02-09 |
Michelle Greene
CTO | Chief Tech/Sci/R&D Officer | 54 | 20-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 55 | 22-09-05 | |
| Director/Board Member | 71 | 13-09-11 | |
Gregory Kenny
CHM | Chairman | 71 | 06-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-19 | 108.2 | +2.07% | 1,486,096 |
| 24-04-18 | 106 | -0.49% | 1,541,130 |
| 24-04-17 | 106.5 | -0.61% | 1,618,273 |
| 24-04-16 | 107.2 | +0.13% | 1,515,804 |
| 24-04-15 | 107 | +1.84% | 1,969,060 |
Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT
More quotes
Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows:
- distribution of pharmaceutical products (92.7%);
- distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.).
The United States accounts for 97.7% of net sales.
Sector
Pharmaceuticals
Calendar
2024-05-01
- Q3 2024 Earnings Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
106
USD
Average target price
113.9
USD
Spread / Average Target
+7.42%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +7.33% | 25.78B | |
| +13.36% | 68.18B | |
| +6.34% | 7.99B | |
| -2.79% | 7.88B | |
| -24.02% | 7.62B | |
| +21.83% | 4.45B | |
| -2.28% | 3.89B | |
| -3.51% | 3.82B | |
| +25.02% | 3.69B | |
| +3.28% | 3.24B |
- Stock Market
- Equities
- CAH Stock
